⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BYSI News
BeyondSpring Inc. Ordinary Shares
Form 8-K
sec.gov
BYSI
Form 8-K
sec.gov
BYSI
Form 8-K
sec.gov
BYSI
Form 8-K
sec.gov
BYSI
BeyondSpring Announces FDA Fast Track Designation for Plinabulin in Post-ICI Non-Squamous NSCLC and Strategic Transaction to Advance Global Phase 3 DUBLIN-4 Trial Toward Planned Interim Analysis
globenewswire.com
BYSI
Form 8-K
sec.gov
BYSI
Form 8-K
sec.gov
BYSI
BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
BYSI
Form 8-K/A
sec.gov
BYSI
BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value
globenewswire.com
BYSI